Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

LESSONS LEARNED: Trials dedicated to metastatic uveal melanoma are needed because of the poor prognosis of this rare cancer and because its biology is distinct from that of cutaneous melanoma. Agents targeting the MEK/ERK/MAP kinase pathways are being tested. BACKGROUND. In experimental models, beva...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Piperno-Neumann, Sophie, Diallo, Alhassane, Etienne-Grimaldi, Marie-Christine, Bidard, François-Clément, Rodrigues, Manuel, Plancher, Corine, Mariani, Pascale, Cassoux, Nathalie, Decaudin, Didier, Asselain, Bernard, Servois, Vincent
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2016
Gaiak:
Clinical Trial Results
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786360/
https://ncbi.nlm.nih.gov/pubmed/26911405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0501
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak